0
0
A groundbreaking study published in September 2025 by researchers from The University of Texas MD Anderson Cancer Center reveals that the sugar combination found in most sweetened beverages—glucose and fructose—directly fuels the spread of colorectal cancer (CRC). This latest research provides important insights for both healthcare professionals and the general public into the harmful effects of sugary drinks beyond the well-known metabolic risks like obesity and diabetes.
What the Study Found
The researchers conducted preclinical experiments exposing colorectal cancer cells to the common glucose-fructose mixture found in sodas, packaged fruit juices, and many “health” beverages. They observed a significant increase in the cancer cells’ ability to migrate and invade other organs, particularly the liver, a frequent site of colorectal cancer metastasis. This effect was not observed with glucose or fructose alone but only when combined, highlighting a unique biological interaction.
Key to this process is the activation of an enzyme called sorbitol dehydrogenase (SORD). This enzyme alters cellular energy metabolism, increasing the NAD⁺/NADH ratio, which essentially gives cancer cells more energy to spread aggressively. In simpler terms, the sugary drinks provide both the “fuel” and the “engine boost” for cancer cells to become more invasive.
Epidemiological Support
Supporting these laboratory findings, large population studies have demonstrated a link between sugary drink consumption and higher risk of early-onset colorectal cancer, especially among women under age 50. For example, a study of nearly 100,000 women found that consuming two or more sugary drinks per week doubled their risk of developing colorectal cancer before age 50. This aligns with the preclinical results by showing the clinical relevance of sugar intake to cancer development, independent of obesity.
Other cohort studies have illustrated increased incidence and mortality related to sugar intake, particularly in the proximal colon, with hazard ratios around 1.18 to 1.42 per increment of sugar consumption, underscoring the dose-dependent nature of this risk.
Expert Commentary
Dr. Yun, a lead researcher in the field, commented that “fructose is not essential for the survival and growth of normal cells, which suggests that therapies targeting fructose metabolism could be explored.” However, he emphasized that public health messages advocating reduced consumption of sugary drinks may have the most significant impact on preventing colorectal cancer progression.
Another expert, Dr. Yin Cao, associate professor at Washington University School of Medicine, highlighted the public health concern raised by rising early-onset CRC rates and the role of diet, noting that these cancers tend to be more advanced at diagnosis and that reducing sugar intake in adolescents and adults could be an important preventive approach.
Context and Public Health Implications
Colorectal cancer incidence has been rising among younger adults globally over the past few decades, coinciding with increases in sugary drink consumption. This study provides a plausible mechanistic explanation connecting dietary habits to the cancer epidemic, reinforcing recommendations from cancer societies to reduce sugary beverage intake.
Most sugary drinks contain high-fructose corn syrup, a roughly equal combination of glucose and fructose, which as shown, uniquely influences cancer cell metabolism and spread. Unlike simple obesity-related mechanisms, this research suggests that sugar directly enhances tumor aggressiveness. This may necessitate new dietary guidelines for cancer patients and those at risk, including limiting or avoiding sugary beverages during treatment as well as prevention.
Limitations and Balanced View
While compelling, the majority of these new mechanistic findings come from laboratory and animal models, which require further validation in extensive human clinical trials. The epidemiological data support association but cannot definitively prove causation, and there may be confounders such as overall diet quality and lifestyle factors. Moreover, genetic predisposition and environmental exposures also influence colorectal cancer risk.
Nevertheless, reducing sugar-sweetened beverage consumption is a low-risk public health intervention with potential benefits beyond cancer prevention, including reduced obesity and metabolic disease rates. This balanced perspective supports advising caution without overstating the certainty of the findings.
What This Means for Individuals
For the general public and healthcare providers, these findings provide an additional reason to minimize sugary drink consumption. Opting for water, unsweetened tea or coffee, and whole fruits instead of sodas and sweetened juices can help reduce colorectal cancer risk, especially among younger adults and those with family histories.
Cancer patients should consult their healthcare teams about diet recommendations, as some guidelines have traditionally suggested sugary drinks for caloric intake during treatment. This research suggests re-evaluation to avoid potentially promoting metastasis-driving sugar mixes.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
